1 Introduction Prader-Willi syndrome (PWS) is a rare genetic disorder characterized by impaired hypothalamic development and function with an estimated incidence of 1 per 20,000 newborns ( Patients with PWS experience complex nutritional, neurodevelopmental, metabolic and behavioral changes that drive obesity development ( Obesity management in PWS typically includes a calorie-restricted diet, strict control of food access, regular physical activity and behavioral interventions ( 2 Case series 2.1 Patient 1 A 28-year-old female with PWS, resulting from uniparental disomy, was evaluated at our Endocrinology Unit
Repeated daily injections for seven days did not induce tolerance to its analgesic effects
The bioavailability of 25(OH)VD 3 in the blood in response to dietary VD intake varies significantly among individual subjects and is dependent on the status of the VD metabolism genes 14,15,16,17
Clinical outcomes range widely, and any provider making fixed guarantees is a marketing operation, not a medical one
Khi tham kho bi vit, ch em c th yn tm, la chn sn phm m mnh yu thch
Proportional hazards tests and diagnostics based on weighted residuals
